Navigation Links
CSL Behring Awards LEAD Grant to Patient Organizations to Educate Constituents on State Insurance Exchanges
Date:12/2/2011

KING OF PRUSSIA, Pa., Dec. 2, 2011 /PRNewswire/ -- CSL Behring announced today that it has awarded a $40,000 advocacy grant to the American Plasma Users Coalition (A-PLUS) through its Local Empowerment for Advocacy Development (LEAD) program. LEAD grants support the grassroots advocacy efforts of organizations that help people who use plasma-derived or recombinant therapies to manage rare and serious medical disorders. CSL Behring has awarded more than $600,000 in grants to patient organizations since the LEAD program was established in 2008.

(Logo: http://photos.prnewswire.com/prnh/20100914/PH63692LOGO)

The grant will be used to create the A-PLUS State Exchange Project, which will educate state advocates on the development of state insurance exchanges, including federally defined essential health benefits that establish the minimum requirements of exchanges.  The project will also help state advocates educate patients about implementation of the exchanges and how they can participate to ensure that access to specialized care and treatments will be maintained in the plans offered through the state insurance exchanges.

A-PLUS partners include:

  • Alpha-1 Association
  • Alpha-1 Foundation
  • Committee of Ten Thousand
  • GBS/CIDP Foundation International
  • Hemophilia Federation of America
  • Immune Deficiency Foundation
  • Jeffrey Modell Foundation
  • National Hemophilia Foundation
  • Patient Services Incorporated
  • Platelet Disorder Support Association

Larry LaMotte, Director of Government Affairs for the Immune Deficiency Foundation said, "This project will allow each organization's volunteers to be educated and trained to advo
'/>"/>

SOURCE CSL Behring
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Overview of CSL Behring Innovations in Recombinant Technologies Presented at International Conference
2. CSL Behring Marks World Hemophilia Day by Announcing the Winners of the CSL Behring - Prof. Heimburger Award 2011
3. CSL Behring Awards Advocacy Grants to Patient Groups in Maryland, New England, the Midwest and Washington
4. ProFibrix and CSL Behring Enter Into Fibrinogen and Thrombin Supply Agreement
5. CSL Behrings Innovative HeliTrax(SM) System Helps Physicians Manage Hemophilia A Patients
6. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
7. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
8. BioCrossroads Awards Indiana Life Sciences Leaders
9. 1 Award Winner and 9 Prize Winners in the EFQM Business Excellence Awards
10. Cellular Dynamics Internationals (CDI) Human Induced Pluripotent Stem Cell (iPSC) Technology Named the Gold Winner in The Wall Street Journal 2011 Technology Innovation Awards
11. Parent Project Muscular Dystrophy Awards End Duchenne Grant to University of Pennsylvanias Dr. Tejvir S. Khurana
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... results of a new study led by George ... evidence that nucleation of ice in small droplets ... water,s behavior at the nanoscale. The formation of ... scientific research question whose answer also has important ... , The crystallization of ice from supercooled water ...
(Date:5/21/2013)... The congress of the ERA-EDTA (European Renal Association ... congress in Europe on nephrology ... Istanbul to share their knowledge ... have been presented: / (1) Gupta, A ... REDUCES ESA USE" By SFP-iron administration, the ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 ... services company for clinical trials, announced today it ... Solutions, LLC. Clinverse’s ClinPay® FLS eClinical commerce ... payment process. SpendMD ™, Aggregate Spend ... solution for tracking and reporting transfer of value ...
(Date:5/21/2013)... ALBANY, New York , May 21, 2013 /PRNewswire/ ... published by Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip ... Science Research, IVD Tests) - U.S. Industry Analysis, Size, Share, ... USD 2.4 billion in 2011 and is expected to ... 2018, to reach an estimated value of USD 4.7 ...
Breaking Biology Technology:Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5
... Scyld ClusterWare with next generation genomic analysis sequencing platform ... ... 27, 2009 -- Penguin Computing, the leading provider of HPC ... with Applied Biosystems, a division of Life Technologies Corporation. ...
... /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ... corporate partner, Boston Scientific Corporation (NYSE: ... Food and Drug Administration (FDA) to market its ... highly deliverable, next-generation drug-eluting stent (DES) specifically designed ...
... 2009 Senomyx, Inc. (Nasdaq: SNMX ), ... discover and develop novel flavor ingredients for the food, ... of David L. Linemeyer, Ph.D., to the position of ... of experience in directing biology research programs and collaborative ...
Cached Biology Technology:Penguin Computing Forms OEM Agreement with Applied Biosystems for Scyld ClusterWare 2Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system 2Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system 3Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system 4Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system 5SENOMYX ANNOUNCES APPOINTMENT OF DAVID L. LINEMEYER, PH.D., AS VICE PRESIDENT, BIOLOGY 2SENOMYX ANNOUNCES APPOINTMENT OF DAVID L. LINEMEYER, PH.D., AS VICE PRESIDENT, BIOLOGY 3
(Date:5/20/2013)... University of Minnesota Medical School researchers from the Masonic ... University,s Brain Tumor Program, have developed a new mouse ... allow them to discover new genes and gene pathways ... published this week in the journal Nature Genetics ... in the lab of David Largaespada, Ph.D., professor in ...
(Date:5/20/2013)... that a compound abundant in the Mediterranean diet takes ... By altering a very specific step in gene regulation, ... that die as scheduled. , One way that cancer ... cause them to die on a regular cycle that ... led by Ohio State University researchers, found that a ...
(Date:5/20/2013)... at the University of Bristol and published online today ... light on how the brain and inner ear developed ... of Earth Sciences, together with Tom Hbner from the ... 150 million year old dinosaurs. , The two palaeontologists ... lettowvorbecki : a very young (juvenile) individual of ...
Breaking Biology News(10 mins):U of M researchers develop model for better testing, targeting of MPNST 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3Fossil brain teaser 2
... DURHAM, N.H. Researchers from the University of New ... help organic dairy farmers better produce and market their ... of Agriculture (USDA) National Institute of Food and Agriculture ... Vermont, Cornell, and the USDA, well as UNH, the ...
... China - BGI, the world,s largest genomic organization, today ... superior performance of RNA-Seq in predicting patient outcomes as ... by the U.S. Food and Drug Administration (FDA). The ... of the MicroArray Quality Control (MAQC), aimed at assessing ...
... AUGUSTA, Ga. Examining the chin and upper and ... for excessive hair growth in women, a key indicator of ... find a way to identify this problem in women that ... Azziz, reproductive endocrinologist and President of Georgia Health Sciences University. ...
Cached Biology News:UNH-led project to boost Northeast organic dairy industry 2UNH-led project to boost Northeast organic dairy industry 3BGI to play a pivotal role in demonstrating the superior performance of RNA-Seq 2Women's chin, abdomen are good indicators of excessive hair growth 2Women's chin, abdomen are good indicators of excessive hair growth 3
Mouse monoclonal antibody raised against a partial recombinant ARHGEF11. NCBI Entrez Gene ID = ARHGEF11...
Mouse monoclonal antibody raised against a partial recombinant MYO7A. NCBI Entrez Gene ID = MYO7A...
... ,High Quality, Functionally-Validated, Ion Channel Cell Lines ... having a critical role in nerve and ... function in pain, CNS and the heart. ... investigated in therapeutic areas, such as neuropathic ...
... PrecisION Ion Channel Cell Lines ,High Quality, ... channels are well known for having a ... and consequently have a key function in ... modulate ion channels have been investigated in ...
Biology Products: